PIR and neoplasm: The multiple low-dose treatment induced tumor cell and vascular apoptosis in the marginal site but not in the central site of the tumor, suggesting that a small number of Pir-PLGA NP-loaded AdSCs were not able to enter the tumor due to their spontaneous apoptosis as a result of pirarubicin release even though they could reach the marginal site during all three treatments.